Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatologic Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05940311
What this trial is testing

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

Who this might be right for
Liquid BiopsyMelanoma (Skin)Melanoma Stage III+1 more
Regina Elena Cancer Institute 20
Post-approval studies (Phase 4)Study completedNCT02767271
What this trial is testing

Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris

Who this might be right for
Tinea PedisTinea Cruris
Bausch Health Americas, Inc. 30
Post-approval studies (Phase 4)UnknownNCT04555707
What this trial is testing

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Who this might be right for
Psoriasis
Derm Research, PLLC 30
Early research (Phase 1)Study completedNCT01215500
What this trial is testing

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

Who this might be right for
TumorCancerMelanoma+2 more
University of Chicago 63
Not applicableUnknownNCT02312700
What this trial is testing

An Interactive Empowerment Tool for Breast Cancer Patients

Who this might be right for
Breast CancerEmpowerment
University of Milan 100
Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)Study completedNCT00498836
What this trial is testing

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Clavis Pharma 18
Early research (Phase 1)WithdrawnNCT01219907
What this trial is testing

Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage IV Breast Cancer
University of Washington
Not applicableActive Not RecruitingNCT04549571
What this trial is testing

Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Alliance for Clinical Trials in Oncology 543
Not applicableStudy completedNCT00959244
What this trial is testing

Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105

Who this might be right for
Breast Cancer
University of Nebraska 100
Testing effectiveness (Phase 2)Study completedNCT02768207
What this trial is testing

Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Study completedNCT01516307
What this trial is testing

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Who this might be right for
Metastatic Breast Cancer
OBI Pharma, Inc 349
Not applicableStudy completedNCT01543711
What this trial is testing

Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment

Who this might be right for
Breast CancerPainPost Operative Pain+2 more
Rigshospitalet, Denmark 2,411
Very early researchStudy completedNCT04971200
What this trial is testing

Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo

Who this might be right for
Skin and Connective Tissue DiseasesSkin DiseasesPigmentation Disorder+3 more
Premier Specialists, Australia 12
Not applicableUnknownNCT05925907
What this trial is testing

Cross-cultural Adaptation of the 'Cold Intolerance Severity Score' (CISS) to the Dutch Language.

Who this might be right for
Hand Injuries
Erasmus Medical Center 100
Large-scale testing (Phase 3)Ended earlyNCT00066807
What this trial is testing

Premenopausal Endocrine Responsive Chemotherapy Trial

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 29
Not applicableUnknownNCT05902611
What this trial is testing

The Relationship Between Body Mass Index, Dental Eruption and Dental Caries Prevalence in School Children

Who this might be right for
Body Mass IndexDental CariesEruption
Al-Azhar University 1,224
Not applicableStudy completedNCT03845400
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Who this might be right for
Hereditary Angioedema (HAE)
Shire 168
Early research (Phase 1)Study completedNCT00072592
What this trial is testing

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableUnknownNCT03979911
What this trial is testing

Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsHER-2 Gene Amplification
University Hospital, Brest 63
Next Page